{
  "paper_metadata": {
    "pmid": "38214277",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Ala97Ser",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 13,
        "demographics": "Age range: 59.33\u00b15.5 years (eplontersen group), 62.43\u00b16.2 years (control group); 83% male in eplontersen group, 71% male in control group.",
        "phenotype": "Hereditary transthyretin amyloid cardiomyopathy (hATTR\u2010CM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 13,
        "affected_count": 6,
        "unaffected_count": 7,
        "uncertain_count": null,
        "penetrance_percentage": 46.15,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation."
        },
        {
          "individual_id": "C1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
        },
        {
          "individual_id": "C2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
        },
        {
          "individual_id": "C3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
        },
        {
          "individual_id": "C4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
        },
        {
          "individual_id": "C5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
        },
        {
          "individual_id": "C6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "hATTR\u2010CM",
          "evidence_sentence": "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
        }
      ],
      "functional_data": {
        "summary": "Eplontersen treatment may be effective in patients with hereditary transthyretin amyloid cardiomyopathy.",
        "assays": []
      },
      "segregation_data": "The A97S mutation is associated with hATTR\u2010CM.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the potential efficacy of eplontersen in treating hATTR\u2010CM.",
      "key_quotes": [
        "All patients in the eplontersen group (100%) carried the Ala97Ser (A97S) mutation.",
        "One of the 7 patients in the control group (14%) carried the Glu89Lys (E89K) mutation, whereas the other 6 carried the A97S mutation."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Baseline demographic and clinical variables of the 2 groups",
      "variants_extracted": 1
    },
    {
      "table_name": "Table 2",
      "table_caption": "Biochemical, Echocardiographic, and 99mTc\u2010PYP Data Before and After Treatment in the Eplontersen Group and the Control Group",
      "variants_extracted": 0
    },
    {
      "table_name": "Table 3",
      "table_caption": "99mTc\u2010PYP Cardiac Data Changes Between the Eplontersen Group and the Control Group",
      "variants_extracted": 0
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for the TTR gene was extracted successfully."
  }
}